MCD

A record yield above 3% is a real draw for income investors, but it exists because the share price has fallen roughly 18% this year and sits near its 52-week low. US comparable sales turned slightly negative in July, analysts have issued cautious ratings, and Evercore warns of possible tax-loss selling as funds rotate elsewhere. The income case supports the stock while the operational and flow headwinds weigh on it. When the supportive and negative forces are this evenly matched, the honest read is balance rather than a bet either way.

Second-quarter adjusted earnings came in at $3.38 per share, ahead of the $3.32 estimate. That beat matters because it shows the franchise model can still grow profit even as customer traffic softens at home. The blemish was US comparable sales, which turned slightly negative in July. So profitability is holding up while sales momentum is not, and the next leg for the share price likely depends on whether comparable sales stabilise rather than on earnings alone.

Two things, in either direction. Positively: an inflection in US comparable sales, the announced 50th consecutive dividend increase, or a rebound above the $260 area that would suggest a short-term bottom is forming. Negatively: further sales deterioration, renewed tax-loss selling into newly listed AI names, or a decisive break below the $250 support zone. The upcoming US jobs and inflation releases could also reset expectations for consumer spending, which feeds directly into the trade-down argument.

Partly. Its low beta of 0.41 and the fast-food model mean it tends to hold up better than the wider market when consumers trade down during tighter times, and bulls frame the current sell-off as an opportunity rather than a value trap. But defensive does not mean immune: negative comps, cautious analyst coverage and the risk of fund-driven selling are real near-term pressures. It behaves like a defensive income holding whose price recovery still depends on sales stabilising.